What is Wesper?
Headquartered in New York, Wesper operates at the intersection of digital health and sleep medicine. The company provides a sophisticated, accessible platform that enables healthcare providers to capture and analyze comprehensive sleep data. By streamlining the diagnostic process, Wesper empowers clinical practices to enhance the quality of care while simultaneously scaling their sleep testing services. The firm's technology addresses critical gaps in traditional sleep monitoring, offering a non-invasive, efficient alternative that aligns with the modern shift toward decentralized and remote patient monitoring solutions.
How much funding has Wesper raised?
Wesper has raised a total of $7.5M across 1 funding round:
Series A
$7.5M
Series A (2022): $7.5M with participation from Ceros Capital Markets
Key Investors in Wesper
Ceros Capital Markets
Ceros Capital Markets is a global investing platform that specializes in fundraising for MedTech and Biotech companies, focusing on disruptive technologies in medical devices, robotics, and digital health.
What's next for Wesper?
Looking ahead, Wesper is poised to leverage its recent capital infusion to deepen its penetration into the enterprise healthcare market. The strategic roadmap likely involves enhancing the platform's analytical capabilities and integrating more robust diagnostic tools to support a broader range of sleep-related conditions. As the demand for high-fidelity, remote-capable medical devices continues to rise, Wesper's focus on clinical-grade data accessibility positions it as a key player in the future of sleep medicine. The company will likely prioritize scaling its service delivery model and forging deeper partnerships with institutional healthcare providers to solidify its role as an essential component of the modern diagnostic ecosystem.
See full Wesper company page
